Yesterday, the FTC issued a final rule making significant changes to the content of HSR filings. The new rule will require filing parties to provide substantially more documents and info...
On March 5, 2024, the FTC, the DOJ and the U.S. Department of Health and Human Services announced that they are seeking public comment on private equity investment in the healthcare secto...
The Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds and filing fee amounts, up to a $2.335 million fee for the largest deals. Under the ...
The Federal Trade Commission has announced revised thresholds for Section 8 of the Clayton Act. Under the new thresholds, a person may not serve as a director or officer of two competing...
Last week, the FTC settled a director interlock lawsuit with EQT/Quantum, which is notable for three key reasons: (1) it confirms the FTC’s focus on enforcing the interlocking directora...
Proposed changes to the HSR Form and Instructions would, if adopted, substantially increase the time and cost of compliance for private equity firms. The proposed rules would require mor...
On July 19, 2023, the DOJ and FTC released a draft overhaul of the merger guidelines (the Draft Guidelines). Some portions of the Draft Guidelines are consistent with agency practice fro...
The U.S. antitrust authorities have proposed extensive changes to the Hart-Scott-Rodino filing requirements. If implemented, these changes will obligate filing parties to provide substant...
On February 3, the DOJ’s Antitrust Division withdrew three “outdated” policy statements. Those statements described certain antitrust safe harbors that companies in the healthcare ...
The Federal Trade Commission (FTC) has announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds and filing fee amounts, up to a $2.25 million fee for the largest deals. Under th...
